| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
72,227 |
57,522 |
$4.68M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
87,016 |
67,991 |
$4.16M |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
19,559 |
15,846 |
$2.00M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
18,792 |
15,370 |
$1.22M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
30,388 |
23,961 |
$1.07M |
| 99199 |
Unlisted special service, procedure or report |
172,932 |
128,901 |
$840K |
| 83970 |
|
14,154 |
11,682 |
$599K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
15,344 |
12,704 |
$466K |
| 86769 |
|
9,946 |
8,010 |
$351K |
| 80061 |
Lipid panel |
18,968 |
15,876 |
$254K |
| 80053 |
Comprehensive metabolic panel |
21,507 |
18,668 |
$191K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21,424 |
18,540 |
$172K |
| 99406 |
|
24,442 |
19,218 |
$165K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,458 |
1,827 |
$158K |
| 84480 |
|
9,476 |
7,831 |
$138K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13,985 |
11,617 |
$132K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13,449 |
8,787 |
$127K |
| 94375 |
|
9,393 |
7,799 |
$116K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,963 |
6,294 |
$115K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,204 |
951 |
$106K |
| 84439 |
|
9,895 |
8,159 |
$91K |
| 99215 |
Prolong outpt/office vis |
1,467 |
1,166 |
$89K |
| 94060 |
|
3,210 |
2,706 |
$74K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,470 |
1,806 |
$70K |
| 82607 |
|
4,269 |
3,594 |
$66K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,407 |
1,792 |
$52K |
| 86703 |
|
4,036 |
3,247 |
$49K |
| 71046 |
Radiologic examination, chest; 2 views |
4,038 |
3,288 |
$47K |
| 94729 |
|
3,207 |
2,704 |
$47K |
| 94726 |
|
3,206 |
2,702 |
$47K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
917 |
724 |
$44K |
| 36415 |
Collection of venous blood by venipuncture |
28,972 |
23,250 |
$40K |
| 82746 |
|
2,355 |
1,993 |
$36K |
| 82728 |
|
2,541 |
2,139 |
$35K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
587 |
460 |
$35K |
| 99442 |
|
1,019 |
647 |
$34K |
| 83735 |
|
4,531 |
3,788 |
$31K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
227 |
127 |
$30K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
361 |
320 |
$27K |
| 93000 |
|
2,723 |
2,308 |
$26K |
| 81025 |
|
4,176 |
3,224 |
$25K |
| 83550 |
|
2,708 |
2,285 |
$25K |
| 99443 |
|
360 |
236 |
$21K |
| 80050 |
General health panel |
1,951 |
1,598 |
$19K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
73 |
44 |
$14K |
| 90791 |
Psychiatric diagnostic evaluation |
220 |
159 |
$14K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
329 |
248 |
$14K |
| 83540 |
|
2,038 |
1,694 |
$14K |
| 82962 |
|
11,529 |
8,748 |
$13K |
| 86431 |
|
1,968 |
1,664 |
$12K |
| 86803 |
|
746 |
572 |
$10K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,620 |
1,381 |
$10K |
| 84550 |
|
1,979 |
1,671 |
$9K |
| 87340 |
|
677 |
519 |
$6K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
147 |
129 |
$6K |
| 90756 |
|
715 |
574 |
$6K |
| 90688 |
|
1,085 |
756 |
$6K |
| 99401 |
|
284 |
213 |
$6K |
| 99205 |
Prolong outpt/office vis |
47 |
37 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
61 |
49 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
129 |
108 |
$5K |
| 81002 |
|
3,100 |
2,464 |
$5K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,210 |
1,019 |
$3K |
| 94618 |
|
287 |
228 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,533 |
2,839 |
$2K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
41 |
36 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
833 |
647 |
$2K |
| 84403 |
|
63 |
62 |
$2K |
| 84402 |
|
63 |
62 |
$2K |
| 99490 |
Ccm add 20min |
166 |
157 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
698 |
565 |
$2K |
| 72100 |
|
90 |
70 |
$1K |
| 99233 |
Prolong inpt eval add15 m |
38 |
12 |
$1K |
| 99407 |
|
93 |
74 |
$1K |
| 83001 |
|
51 |
51 |
$1K |
| 83002 |
|
51 |
51 |
$1K |
| 95117 |
|
161 |
40 |
$913.32 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,069 |
2,472 |
$890.73 |
| 90661 |
|
74 |
69 |
$783.60 |
| 86328 |
|
18 |
17 |
$768.91 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
29 |
27 |
$739.56 |
| 84270 |
|
26 |
26 |
$686.08 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
45 |
43 |
$511.19 |
| 87077 |
|
103 |
82 |
$463.14 |
| 93922 |
|
13 |
12 |
$406.85 |
| 20610 |
|
13 |
12 |
$388.93 |
| 46221 |
|
19 |
13 |
$383.40 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
62 |
25 |
$367.38 |
| 96146 |
|
334 |
203 |
$283.44 |
| 80348 |
|
223 |
184 |
$245.40 |
| 91200 |
|
19 |
14 |
$200.79 |
| 3044F |
|
5,536 |
4,506 |
$180.00 |
| 82044 |
|
75 |
63 |
$121.10 |
| 96103 |
|
120 |
105 |
$73.31 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
520 |
410 |
$72.61 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
123 |
98 |
$9.77 |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
473 |
378 |
$0.99 |
| 1111F |
|
17 |
12 |
$0.01 |
| 4004F |
|
6,467 |
5,424 |
$0.00 |
| 3078F |
|
11,997 |
10,079 |
$0.00 |
| 3077F |
|
1,743 |
1,499 |
$0.00 |
| 3051F |
|
218 |
164 |
$0.00 |
| 3046F |
|
172 |
136 |
$0.00 |
| 3050F |
|
1,147 |
994 |
$0.00 |
| 1159F |
|
225 |
184 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
228 |
193 |
$0.00 |
| 99072 |
|
29 |
29 |
$0.00 |
| 3288F |
|
63 |
55 |
$0.00 |
| 3048F |
|
3,898 |
3,346 |
$0.00 |
| 3049F |
|
2,184 |
1,848 |
$0.00 |
| 3074F |
|
12,922 |
10,760 |
$0.00 |
| 3008F |
|
23,903 |
19,952 |
$0.00 |
| 3075F |
|
2,148 |
1,905 |
$0.00 |
| 1170F |
|
214 |
166 |
$0.00 |
| 3080F |
|
381 |
333 |
$0.00 |
| 1125F |
|
996 |
888 |
$0.00 |
| 3079F |
|
5,201 |
4,489 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
574 |
478 |
$0.00 |
| 4010F |
|
1,230 |
1,037 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
785 |
649 |
$0.00 |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
40 |
37 |
$0.00 |
| G0296 |
Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) |
337 |
272 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
38 |
38 |
$0.00 |
| 3052F |
|
120 |
99 |
$0.00 |
| 3060F |
|
41 |
34 |
$0.00 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
20 |
19 |
$0.00 |